Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Drug Name | BNT141 |
Trade Name | |
Synonyms | BNT-141|BNT 141 |
Drug Descriptions |
BNT141 consists of an mRNA encoding an anti-CLDN18.2 monoclonal antibody contained within a lipid nanoparticle, which may lead to inhibition of tumor-expressed CLDN18.2, potentially resulting in tumor cell death (NCI Drug Dictionary). |
DrugClasses | |
CAS Registry Number | NA |
NCIT ID | C179620 |
Therapy Name | Drugs | Efficacy Evidence | Clinical Trials |
---|---|---|---|
BNT141 | BNT141 | 0 | 1 |
BNT141 + Gemcitabine + Nab-paclitaxel | BNT141 Gemcitabine Nab-paclitaxel | 0 | 1 |